Diabetes Adipositas Zentrum Zürich
Zollikerberg 8125
0 studies enrolling now · 3 studies all time
What they study most
Diabetes Mellitus, Type 2, Obesity, Overweight, Type 2 Diabetes
Studies at this site
- Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide — Running, not enrolling
- A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight — Withdrawn before enrolling
- A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2) — Completed